Stevie Elam: From Childhood Cancer Survivor to Division I Basketball Star
admin The journey of Stevie Elam, from a toddler facing a life-threatening Stage 4 Wilms tumor...
st jude
Resilience in the Face of Childhood Cancer The Journey of Lily and the Growing Challenges of Neuroblastoma Treatment
The medical journey of a two-year-old girl named Lily has highlighted the complex and often...
Breakthrough Immunotherapy Clinical Trial Offers New Hope for Children Facing Incurable Brain Tumors
In the specialized field of pediatric oncology, the diagnosis of a diffuse midline glioma (DMG)...
CureSearch Awards Young Investigator Grant to Dr. Kathryn Taylor for Innovative Research into High-Grade Pediatric Gliomas
The national non-profit organization CureSearch for Children’s Cancer has officially announced Dr. Kathryn Taylor, PhD,...
Dr. Moghimi & team has tool to treat Acute Myeloid leukemia
Children’s Hospital Los Angeles (CHLA) has announced a significant advancement in the fight against pediatric...
Innovative Immunotherapy Research Led by Dr. Hunter Jonus Offers New Hope for High-Risk Neuroblastoma Patients
The landscape of pediatric oncology is currently witnessing a transformative shift as researchers move beyond...
Legacy of Hope: The Zach Sobiech Osteosarcoma Fund Transforms Pediatric Bone Cancer Research Landscape
The legacy of Zach Sobiech, a Minnesota teenager who gained international recognition for his viral...
Breakthrough Research in Pediatric Diffuse Glioma Receives Strategic Funding Through the 2024 CureSearch Acceleration Initiative Award.
The landscape of pediatric oncology is currently witnessing a pivotal shift as researchers move beyond...
Enough Already: Addressing the Urgent Funding and Research Gaps During Childhood Cancer Awareness Month
Every day across the United States, the lives of children and their families are irrevocably...
FDA Approves OJEMDA as the First Targeted Therapy for Pediatric Low-Grade Glioma with BRAF Alterations
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to OJEMDA (tovorafenib), marking...
